HALOZYME THERAPEUTICS, INC. (HALO) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues
Product sales, net						53.4	46.1	37.8
Royalties						51.0	31.0	9.4

Gross profit
Product sales, net						20.2	16.8	15.1

Mix
Product sales, net						36.4%	34.1%	50.2%
Royalties						34.8%	22.9%	12.5%

Growth
Product sales, net						15.9%	21.8%	54.8%
Royalties						64.6%	228.6%	28460.6%